rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jay Shepard

Director

Company insider

Files Form 4 as: Director, Esperion Therapeutics; Director, Ironwood Pharmaceuticals; Director, Inovio Pharmaceuticals; President and CEO, Aravive; Director, Marinus Pharmaceuticals; Director, Durect.

Every Form 4 they filed

In numbers

Trades disclosed
123
Buys
0
Sells
17
Bought
$0
Sold
$1.5M
Companies
6
Companies where not an officer
5
First trade
26 Sep 2013
Last trade
13 Jul 2026
Last filed
13 Jul 2026

Companies traded

Where they are an officer
AraviveDirector, Officer, Other · last 8 Apr 20200 buys · 17 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Esperion TherapeuticsDirector · Biotechnology · last 13 Jul 20260 buys · 0 sells
IRWD Ironwood PharmaceuticalsDirector · Pharmaceuticals · last 16 Jun 20260 buys · 0 sells
INO Inovio PharmaceuticalsDirector · Biotechnology · last 20 May 20260 buys · 0 sells
Marinus PharmaceuticalsDirector · last 17 Jan 20170 buys · 0 sells
DurectDirector · last 22 Jun 20160 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
13 Jul 2026filed 13 Jul 2026Esperion TherapeuticsBiotechnologySEC FORM 4 Code D—164,472filing
13 Jul 2026filed 13 Jul 2026Esperion Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—21,000filing
13 Jul 2026filed 13 Jul 2026Esperion Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—32,500filing
13 Jul 2026filed 13 Jul 2026Esperion Therapeuticsoption or derivativeSEC FORM 4 Code D—21,000filing
13 Jul 2026filed 13 Jul 2026Esperion Therapeuticsoption or derivativeSEC FORM 4 Code D—32,500filing
13 Jul 2026filed 13 Jul 2026Esperion Therapeuticsoption or derivativeSEC FORM 4 Code D—44,000filing
13 Jul 2026filed 13 Jul 2026Esperion Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—44,000filing
13 Jul 2026filed 13 Jul 2026Esperion TherapeuticsSEC FORM 4 Code D—164,472filing
16 Jun 2026filed 17 Jun 2026IRWD Ironwood PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—63,481 at $0.00filing
16 Jun 2026filed 17 Jun 2026IRWD Ironwood PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—63,481 at $0.00filing
28 May 2026filed 1 Jun 2026Esperion TherapeuticsBiotechnologySEC FORM 4 Code A—79,873 at $0.00filing
28 May 2026filed 1 Jun 2026Esperion TherapeuticsSEC FORM 4 Code A—79,873 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—41,800 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—34,200 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—41,800 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—34,200 at $0.00filing
10 Jun 2025filed 12 Jun 2025IRWD Ironwood PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—45,000 at $0.00filing
29 May 2025filed 2 Jun 2025Esperion Therapeuticsoption or derivativeSEC FORM 4 Code A—44,000 at $0.00filing
29 May 2025filed 2 Jun 2025Esperion TherapeuticsSEC FORM 4 Code A—33,000 at $0.00filing
21 May 2025filed 21 May 2025INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—2,167 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed17

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.